Key features for designing M2 proton channel anti swine flu inhibitors

Journal of the Taiwan Institute of Chemical Engineers

Volumn 42, Issue 5, 2011, Pages 701-708

  Chang, Tung Ti ^a,b   Sun, Mao Feng ^a,b   Chen, Hsin Yi ^c   Tsai, Fuu Jen ^b,c   Lin, Jaung Geng ^a   Chen, Calvin Yu Chian ^a,c,d,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Docking; H1N1; M2 proton channel; Molecular dynamics; Traditional Chinese medicine (TCM)

Indexed keywords

BIO-MOLECULAR; DRUG DESIGN; DRUG-RESISTANCE; FLU PANDEMIC; H1N1; INFLUENZA VIRUS; KEY FEATURE; M2 PROTON CHANNEL; MD SIMULATION; MOLECULAR DYNAMICS SIMULATIONS; PROTEIN-LIGAND INTERACTIONS; PROTON CHANNELS; TRADITIONAL CHINESE MEDICINE; VIRAL INFECTIONS;

COMPUTER SIMULATION; DOCKING; DYNAMICS; MEDICINE; MOLECULAR DYNAMICS; PROTONS;

VIRUSES;

EID: 80052963384     PISSN: 18761070     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtice.2011.01.006     Document Type: Article

References (37)

1. Chen C.Y.C. TCMDatabase@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening in Silico. PLoS ONE 2011, 6:e15939.
2. Chen C.Y. Insights into Designing the Dual-Targeted Her2/Hsp90 Inhibitors. J. Mol. Graph. Model. 2010, 29:21.
3. Chen C.Y. Virtual Screening and Drug Design for Pde-5 Receptor from Traditional Chinese Medicine Database. J. Biomol. Struct. Dyn. 2010, 27:627.
4. Chen C.Y.C. Bioinformatics, Chemoinformatics, and Pharmainformatics Analysis of Her2/Hsp90 Dual-Targeted Inhibitors. J. Taiwan Inst. Chem. Engrs. 2010, 41:143.
5. Chen C.Y.C. Chemoinformatics and Pharmacoinformatics Approach for Exploring the Gaba-a Agonist from Chinese Herb Suanzaoren. J. Taiwan Inst. Chem. Engrs. 2009, 40:36.
6. Chen C.Y.C. Computational Screening and Design of Traditional Chinese Medicine (Tcm) to Block Phosphodiesterase-5. J. Mol. Graph. Model. 2009, 28:261.
7. Chen C.Y.C. De Novo Design of Novel Selective Cox-2 Inhibitors: From Virtual Screening to Pharmacophore Analysis. J. Taiwan Inst. Chem. Engrs. 2009, 40:55.
8. Chen C.Y.C. Pharmacoinformatics Approach for Mpges-1 in Anti-Inflammation by 3d-Qsar Pharmacophore Mapping. J. Taiwan Inst. Chem. Engrs. 2009, 40:155.
9. Chen C.Y.C. Weighted Equation and Rules - A Novel Concept for Evaluating Protein-Ligand Interaction. J. Biomol. Struct. Dyn. 2009, 27:271.
10. Chen C.Y.C. Discovery of Novel Inhibitors for C-Met by Virtual Screening and Pharmacophore Analysis. J. Chin. Inst. Chem. Engrs. 2008, 39:617.
11. Chen C.Y.C. Insights into the Suanzaoren Mechanism-from Constructing the 3d Structure of Gaba-a Receptor to Its Binding Interaction Analysis. J. Chin. Inst. Chem. Engrs. 2008, 39:663.
12. Chen C.Y.C. A Novel Perspective on Designing the Inhibitor of Her2 Receptor. J. Chin. Inst. Chem. Engrs. 2008, 39:291.
13. Chen Y.C. The Molecular Dynamic Simulation of Zolpidem Interaction with Gamma Aminobutyric Acid Type a Receptor. J. Chin. Chem. Soc. 2007, 54:653.
14. Chen Y.C., Chen K.T. Novel Selective Inhibitors of Hydroxyxanthone Derivatives for Human Cyclooxygenase-2. Acta Pharmacol. Sin. 2007, 28:2027.
15. Chen C.Y., Huang H.J., Tsai F.J., Chen C.Y.C. Drug Design for Influenza a Virus Subtype H1n1. J. Taiwan Inst. Chem. Engrs. 2010, 41:8.
16. Chen C.Y., Chang Y.H., Bau D.T., Huang H.J., Tsai F.J., Tsai C.H., Chen C.Y.C. Discovery of Potent Inhibitors for Phosphodiesterase 5 by Virtual Screening and Pharmacophore Analysis. Acta Pharmacol. Sin. 2009, 30:1186.
17. Chen C.Y., Chang Y.H., Bau D.T., Huang H.J., Tsai F.J., Tsai C.H., Chen C.Y.C. Ligand-Based Dual Target Drug Design for H1n1: Swine Flu - A Preliminary First Study. J. Biomol. Struct. Dyn. 2009, 27:171.
18. Chen C.Y.C., Chen G.W., Chen W.Y.C. Molecular Simulation of Her2/Neu Degradation by Inhibiting Hsp90. J. Chin. Chem. Soc. 2008, 55:297.
19. Chen C.Y.C., Chen Y.F., Wu C.H., Tsai H.Y. What Is the Effective Component in Suanzaoren Decoction for Curing Insomnia? Discovery by Virtual Screening and Molecular Dynamic Simulation. J. Biomol. Struct. Dyn. 2008, 26:57.
20. Cheng P.K., Leung T.W., Ho E.C., Leung P.C., Ng A.Y., Lai M.Y., Lim W.W. Oseltamivir- and Amantadine-Resistant Influenza Viruses a (H1n1). Emerging Infect. Dis. 2009, 15:966.
21. Du Q.S., Huang R.B., Wang S.Q., Chou K.C. Designing Inhibitors of M2 Proton Channel against H1n1 Swine Influenza Virus. Plos One 2010, 5:e9388.
22. Helenius A. Unpacking the Incoming Influenza Virus. Cell 1992, 69:577.
23. Hsieh Y.H., Chu F.H., Wang Y.S., Chien S.C., Chang S.T., Shaw J.F., Chen C.Y., Hsiao W.W., Kuo Y.H., Wang S.Y. Antrocamphin a, an Anti-Inflammatory Principal from the Fruiting Body of Taiwanofungus Camphoratus, and Its Mechanisms. J. Agric. Food Chem. 2010, 58:3153.
24. Huang H.J., Chen C.Y., Chen H.Y., Tsai F.J., Chen C.Y.C. Computational Screening and Qsar Analysis for Design of Amp-Activated Protein Kinase Agonist. J. Taiwan Inst. Chem. Engrs. 2010, 41:352.
25. Huang H.J., Lee K.J., Yu H.W., Chen C.Y., Hsu C.H., Chen H.Y., Tsai F.J., Chen C.Y.C. Structure-Based and Ligand-Based Drug Design for Her 2 Receptor. J. Biomol. Struct. Dyn. 2010, 28:23.
26. Huang H.J., Lee K.J., Yu H.W., Chen H.Y., Tsai F.J., Chen C.Y. A Novel Strategy for Designing the Selective Ppar Agonist by The " Sum of Activity" Model. J. Biomol. Struct. Dyn. 2010, 28:187.
27. Ilyushina N.A., Govorkova E.A., Webster R.G. Detection of Amantadine-Resistant Variants among Avian Influenza Viruses Isolated in North America and Asia. Virology 2005, 341:102.
28. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings. Adv. Drug Deliv. Rev. 2001, 46:3.
29. Patil R., Das S., Stanley A., Yadav L., Sudhakar A., Varma A.K. Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing. Plos One 2010, 5.
30. Pinto L.H., Dieckmann G.R., Gandhi C.S., Papworth C.G., Braman J., Shaughnessy M.A., Lear J.D., Lamb R.A., DeGrado W.F. A Functionally Defined Model for the M2 Proton Channel of Influenza a Virus Suggests a Mechanism for Its Ion Selectivity. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:11301.
31. Pinto L.H., Lamb R.A. The M2 Proton Channels of Influenza a and B Viruses. J. Biol. Chem. 2006, 281:8997.
32. Squires B., Macken C., Garcia-Sastre A., Godbole S., Noronha J., Hunt V., Chang R., Larsen C.N., Klem E., Biersack K., Scheuermann R.H. Biohealthbase: Informatics Support in the Elucidation of Influenza Virus Host Pathogen Interactions and Virulence. Nucleic Acids Res. 2008, 36:D497.
33. Stouffer A.L., Acharya R., Salom D., Levine A.S., Di Costanzo L., Soto C.S., Tereshko V., Nanda V., Stayrook S., DeGrado W.F. Structural Basis for the Function and Inhibition of an Influenza Virus Proton Channel. Nature 2008, 451:596.
34. Su C.R., Chen Y.F., Liou M.J., Tsai H.Y., Chang W.S., Wu T.S. Anti-Inflammatory Activities of Furanoditerpenoids and Other Constituents from Fibraurea Tinctoria. Bioorg. Med. Chem. 2008, 16:9603.
35. Sugrue R.J., Hay A.J. Structural Characteristics of the M2 Protein of Influenza a Viruses: Evidence That It Forms a Tetrameric Channel. Virology 1991, 180:617.
36. Tang Y.J., Yang J.S., Lin C.F., Shyu W.C., Tsuzuki M., Lu C.C., Chen Y.F., Lai K.C. Houttuynia Cordata Thunb Extract Induces Apoptosis through Mitochondrial-Dependent Pathway in Ht-29 Human Colon Adenocarcinoma Cells. Oncol. Rep. 2009, 22:1051.
37. Venkatachalam C.M., Jiang X., Oldfield T., Waldman M. Ligandfit: A Novel Method for the Shape-Directed Rapid Docking of Ligands to Protein Active Sites. J. Mol. Graph. Model. 2003, 21:289.